Gastrointestinal issues dominate, including nausea (44-50 percent of patients), vomiting (24-31 percent), diarrhea (30-40 percent), constipation (24-30 percent), and abdominal pain (20-25 percent)
The pathogens identified in PCD are similar to CF but with H
Gut Health Research BPC-157 has a significant body of preclinical research exploring its protective and healing effects on gut tissue, including studies on intestinal barrier integrity and recovery from gut damage
The FDA permits compounding when patients cannot access FDA-approved alternatives due to allergies to inactive ingredients, need for a different dosage form (such as liquid instead of pills), or medication shortages
The effect was due to accelerated angiogenesis but not vasodilation, since there was no significant difference of the blood flow in tails and non-ischemic hind limb between the control and BPC 157 groups